with growth slowdown prior to fledging (25). Among other embryonic and perinatal dinosaurs, the thickness of the CHC has been used as a proxy for altriciality or precocity. Hadrosaurs Maiasaura and Hypacrosaurus preserve "massive amounts" of calcified cartilage and numerous diaphyseal cartilage islands hypothesized to indicate altricial behaviors (18, 19). Epiphyseal histology of the theropod Troodon records thinner CHC with only a few small, deeply located cartilage islands within the diaphysis, consistent with a more precocial growth strategy (19), but, unlike titanosaurs, paravians (including Troodon) are thought to have some degree of parental care (3, 26). UA 9998 CHC regions are thin (~500 mm), with sparse, deep cartilage islands that compare favorably with the CHC of precocial birds nearing fledging (23-25) and some perinatal dinosaurs (19). That said, UA 9998 is only~11% the size of the largest known Rapetosaurus individual (3) (table S2), and it is unreasonable to assume that the thin CHC zones indicate growth slowdown at skeletal maturity. In extant vertebrates, bone elongation also slows during intervals of acute starvation via a decrease in chondroplasia and osteoblastic activity (27, 28). These shifts in cellular activity are signaled by modified metaphyseal morphology as osteogenesis outpaces the rate of cartilage proliferation, eventually restricting the CHC to result in a "stouter" metaphysis with a "sharper" chondro-osseus junction than that in healthy individuals (27). UA 9998 exhibits the stout, sharp CHC expected with acute starvation (27, 28). Drought and its attendant hardships have been well documented for the Maevarano Formation vertebrate assemblage [e.g., (2, 3, 29, 30)]. During the short interval between hatching and drought-related mortality, UA 9998 lived an active, precocial life evidenced by isometric scaling, rapid neonatal growth rates, midcortical remodeling, and calcified cartilaginous metaphyseal morphology.
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Progression through the stages of lymphocyte development requires coordination of the cell cycle. Such coordination ensures genomic integrity while cells somatically rearrange their antigen receptor genes [in a process called variable-diversity-joining (VDJ) recombination] and, upon successful rearrangement, expands the pools of progenitor lymphocytes. Here we show that in developing B lymphocytes, the RNA-binding proteins (RBPs) ZFP36L1 and ZFP36L2 are critical for maintaining quiescence before precursor B cell receptor (pre-BCR) expression and for reestablishing quiescence after pre-BCRinduced expansion. These RBPs suppress an evolutionarily conserved posttranscriptional regulon consisting of messenger RNAs whose protein products cooperatively promote transition into the S phase of the cell cycle. This mechanism promotes VDJ recombination and effective selection of cells expressing immunoglobulin-m at the pre-BCR checkpoint.
L ymphocyte development is characterized by dynamic shifts between quiescence and proliferation. Quiescence promotes variablediversity-joining (VDJ) recombination, the process that generates immunoglobulin and T cell receptor genes, because RAG2 protein expression is restricted to the G 0 -G 1 phase of the cell cycle (1) (2) (3) . In B cells, VDJ recombination leads to expression of an immunoglobulin-m (Igm) heavy chain that, together with the surrogate light chains, forms a precursor B cell receptor (pre-BCR). Signals from the pre-BCR terminate the recombination process and trigger rapid proliferation associated with passage through the pre-BCR checkpoint (4) . Later signals from the pre-BCR reestablish quiescence, allowing immunoglobulin light-chain recombination ( fig. S1A ) (5, 6) .
The ZFP36 family of RNA-binding proteins (RBPs) regulate gene expression posttranscriptionally by promoting mRNA decay (7) . This requires their direct binding to AU-rich elements (AREs) located in the 3′ untranslated regions (3'UTRs) of mRNAs. ZFP36 destabilizes cytokine mRNAs and exerts an anti-inflammatory function (8, 9) . In addition, ZFP36 antagonizes Myc-induced lymphomagenesis (10) , and its paralogs ZFP36L1 and ZFP36L2 have redundant roles in preventing T cell leukemia in mice (11) . The pathways controlled by these RBPs, however, have remained poorly understood.
In our study, all three ZFP36-family mRNAs were expressed throughout B cell development ( fig. S1B ). Conditional genetic deletion demonstrated redundant roles for ZFP36L1 and ZFP36L2 in early B cell development that could not be compensated for by endogenous ZFP36 and that were independent of NOTCH1, a known target of these RBPs ( fig. S2) (11 deleted in pro-B cells ( fig. S3 ). For simplicity, Zfp36l1 f l/f l Zfp36l2 f l/f l Mb1 cre/+ mice will be referred to as DCKO (double conditional knockout) mice, and their Zfp36l1 f l/f l Zfp36l2 f l/f l Mb1 +/+ littermates will be referred to as control mice. DCKO mice displayed reduced cellularity from the pre-B stage onward, culminating in a 98% reduction in the number of mature B cells (Fig. 1, A and B). The proportion of CD43 + cells expressing Igm was greatly diminished (Fig. 1C) , and a variable proportion of DCKO cells transited the pre-BCR checkpoint without Igm expression (Fig. 1D ).
Within the compartment enriched for pro-B cells, DCKO mice had reduced proportions of cells containing one or two V-to-DJ-recombined IgH alleles ( Fig. 1E and fig. S4 ). At later developmental stages, the DCKO mice failed to increase the proportion of recombined IgH alleles to control levels. The decrease in the proportions of V-to-DJ-recombined IgH alleles and Igm + cells within the pro-B and early pre-B cell compartment of DCKO mice was similar, suggesting that the failure to express Igm is not due to an increase in nonproductive joints. Similarly, V-to-J recombination of the Igk lightchain locus was reduced in DCKO late pre-B cells (Fig. 1F) . Thus, DCKO mice display reduced B cell numbers, delayed VDJ recombination, and failure of the pre-BCR checkpoint.
Expression of a productively rearranged Igm transgene failed to restore late pre-B, immature B, or mature B cell numbers in DCKO mice, indicating that reduced VDJ recombination of IgH is not the sole defect (fig. S5) . Consistent with this, we observed an increase in apoptosis of DCKO Igm + late pre-B cells (Fig. 1G) . The increased apoptosis was not susceptible to inhibition by BCL2, and we did not detect a DNA damage response ( fig. S6) late pre-B cell gate were apoptotic, indicating that although Igm -DCKO cells were aberrantly selected, they did not bypass the requirement of pre-BCR expression for continued survival (Fig. 1H) . Within mRNAs that were overrepresented in DCKO late pre-B cell transcriptomes, there was a strong enrichment for pathways promoting cell cycle progression (Fig. 2, A and B, and tables S1 to S4). Because VDJ recombination is inhibited by cell cycle progression, and the pre-BCR checkpoint is mediated by the selective proliferation of Igm + cells, we hypothesized that these aspects of the phenotype might be explained by uncontrolled cell cycle progression in DCKO mice. The apoptosis of DCKO late pre-B cells could be due to delayed light-chain recombination or overexpression of cell cycle regulators; these cells are destined to be quiescent and therefore may not tolerate activation of the E2F pathway, which regulates transition through the cell cycle and DNA synthesis. Loss of E2f 1 has been demonstrated to increase late pre-B cell numbers (12) .
Cell cycle analysis showed an increase in the proportion of DCKO pro-B cells in the S phase (Fig. 2, C and D) . The cyclin-dependent kinase inhibitor p27 (also known as CDKN1B) is known to regulate the cell cycle during pre-B cell development (5), and high expression of p27 (p27 high ) is a marker of cellular quiescence (13) . The proportion of p27 high G 0 cells was markedly reduced in DCKO pro-B cells and was moderately reduced in DCKO early and late pre-B cells (Fig. 2, E and  F) . Thus, ZFP36L1 and ZFP36L2 impose quiescence on developing B cells and inhibit entry into the S phase before expression of the pre-BCR.
We demonstrated that the transcription factors induced by the pre-BCR that promote quiescence in late pre-B cells were expressed in DCKO mice and that p27 mRNA was induced; additionally, factors mediating VDJ recombination were expressed, and the Igk locus was transcriptionally active (fig.  S7 ). Therefore, DCKO late pre-B cells are transcriptionally poised to enter quiescence and undergo VDJ recombination, but posttranscriptional regulation mediated by ZFP36L1 and ZFP36L2 is required for the full activation of these processes.
Consistent with their role in promoting mRNA decay, ZFP36L1-bound transcripts identified by cross-linking immunoprecipitation (iCLIP) (14) were more abundant in DCKO late pre-B cells (Fig. 3A) . Increased mRNA abundance in DCKO late pre-B cells was also associated with AREs in the 3'UTRs of mRNAs ( fig. S8A ) and with ZFP36 binding sites in the human homologs of mouse transcripts ( fig. S8 , B and C) (15) . Thus, the specificity of ZFP36-family proteins is generally conserved across family members, species, and cell types.
ZFP36L1 binding sites were typically associated with AREs (table S5). In the mRNAs identified by iCLIP, cell cycle pathways were strongly enriched (tables S6 and S7), evidence that further connects ZFP36L1 to cell cycle regulation. From among mRNAs implicated in cell cycle control, we identified several candidate targets that have ZFP36L1 binding sites or AREs and that exhibited significant increases in mRNA abundance in DCKO late pre-B cells (Fig. 3B and table S8) . We validated the activity of the ZFP36L1 binding site in Ccne2 (fig.  S9 ). Among the putative targets are the mRNAs encoding PIM-family kinases and components of the CDK2-cyclin E complex that phosphorylates p27, promoting its destruction (16, 17) ; this mechanism is consistent with the reduced p27 protein but equivalent p27 mRNA in DCKO late pre-B cells, relative to those of control mice. Furthermore, the AREs in putative target mRNAs that have roles in cell cycle progression are very highly conserved in mammals (Fig. 3C) . These data strongly suggest that ZFP36L1 and ZFP36L2 directly regulate an evolutionarily conserved posttranscriptional regulon that controls cell cycle progression (18) .
A posttranscriptional mechanism for enforcing quiescence is well suited to the events surrounding the pre-BCR checkpoint, because it can be reversed more rapidly than changes that are mediated at the level of transcription. ZFP36L1 and ZFP36L2 are phosphorylated by MAPKAP2 downstream of p38 MAPK (mitogen-activated protein kinase), and this inhibits their mRNAdestabilizing effects (19) . The activity of p38 is induced downstream of the pre-BCR, providing a mechanism to relieve the repression by ZFP36L1 and ZFP36L2 of mRNAs encoding cell cycle regulators (20) . To examine the effects of ZFP36L1 overexpression at the pre-BCR checkpoint, we generated mice that conditionally expressed ZFP36L1 fused at its N terminus to green fluorescent protein (GFP); we refer to the allele as ROSA26 L1 ( fig. S10 ). There was a significantly reduced proportion of S-phase cells and a significantly increased proportion of G 0 cells in ROSA26 L1/L1 CD2cre pre-B cells, compared with controls (Fig. 3, D and E, and fig. S11, A and B) . Thus, enforced expression of ZFP36L1 suppresses proliferation at the pre-BCR checkpoint.
Cyclin D3, cyclin E2, and their partner kinases were identified among candidate ZFP36L1 and -2 targets in DCKO late pre-B cells. Cyclin D3 has an essential role in pre-BCR-mediated proliferation (21) . Elevated protein expression of cyclin D3 and cyclin E2 was confirmed in DCKO pro-B and early pre-B cells (Fig. 4, A and B, and fig. S12 , A and B), indicating that ZFP36L1 and ZFP36L2 limit the induction of cyclin D3 and cyclin E2 to cells that are transiting pre-BCR selection. In contrast, ROSA26 L1 CD2cre mice failed to properly induce cyclin D3 or cyclin E2 at the proliferative early pre-B cell stage, a result that further reinforces the role of ZFP36L1 in controlling the cell cycle at the point of pre-BCR selection (Fig. 4,  C and D, and fig. S12, C to E) .
Overexpression of cyclin D3 can inhibit VDJ recombination in pre-B cells through a mechanism involving loss of quiescence (22) . Therefore, we treated DCKO and control mice with the CDK4 and -6 inhibitor palbociclib, which inhibits activation of the E2F pathway. Palbociclib treatment increased V-to-DJ recombination at the IgH locus of cells in the pro-B and early pre-B compartment (Fig. 4E and fig. S13, A and B) . Consistent with increased recombination and reduced cell division, the proportion of pro-and pre-B cells containing excised signal circles was increased after palbociclib treatment ( fig. S13, C and D) . Conversely, the frequency of recombination at the IgH locus of late pre-B cells was not restored by palbociclib treatment, reflecting the inhibition of the cell cycle, which prevents the proliferative selection of cells into the late pre-B cell pool (fig. S13E). Igk recombination was also restored in DCKO late pre-B cells after palbociclib treatment (Fig. 4F and fig. S13F ). This indicates that the delays in VDJ recombination are caused by loss of quiescence in DCKO pro-and pre-B cells.
We found that increased Zfp36-family member mRNA expression was typically associated with quiescent cell phenotypes (Fig. 4G) . Therefore, we generated a ZFP36L1 −/− HCT116 human colorectal carcinoma cell line and measured the expression of cyclin D3 and of cyclin D1, a putative ZFP36L1 target that is not expressed in B cells (15, 23) . Expression of both D-type cyclins was increased in ZFP36L1 −/− HCT116 cells compared with the parental line (Fig. 4H) . Additionally, genetic experiments have shown that the loss of Zfp36l2 leads to depletion of hematopoietic stem cells (24) , and the loss of Zfp36 is associated with increased muscle satellite activation (25) . Thus, these RBPs probably form part of a general mechanism for the posttranscriptional regulation of quiescence. As many as 10% of human mRNAs contain AREs (26) ; this may enable interdependent cellular processes to be coordinated by the ZFP36 family. The dynamics of the transition between the G 0 -G 1 and S phases are characterized by switching behavior that is mediated by positive feed-forward regulation in the E2F pathway (27) ; thus, this pathway may be particularly sensitive to moderate changes in the abundance of its components, as measured in DCKO pre-B cells (Fig.  3A) . We propose that ZFP36L1 and ZFP36L2 suppress the expression of limiting factors for E2F pathway activation (16, (28) (29) (30) (31) and DNA replication licensing, thus providing a robust mechanism for reversibly stabilizing the G 0 -G 1 state. This mechanism would contribute to the ability of the progenitor cell populations to respond appropriately and dynamically to both mitogenic and antiproliferative signals. W e recently identified a core set of genes specifically associated with tissue residency of CD8 T cells (1) . Genes upregulated in Trm cells included Zfp683 (LOC100503878), also termed "homolog of Blimp1 in T cells" (Hobit), a transcription factor that we previously identified in NKT cells (2) . Virus-specific CD8 T cells in skin, but not spleen, after herpes simplex virus (HSV) infection expressed large amounts of Hobit transcripts (Fig. 1A) . Hobit expression in skin T cells was low at day 8 and high by day 30 postinfection (p.i.) (Fig. 1A) . This was in contrast to Prdm1 (hereafter, Blimp1), which peaked at day 8 p.i. and persisted at lower levels in splenic and skin memory CD8 T cells (Fig. 1B) . Similarly, after acute infection with lymphocytic choriomeningitis virus (LCMV), Hobit was specifically induced in gut Trm cells, whereas Blimp1 was expressed ubiquitously in memory CD8 T cells ( fig. S1, A  and B) . Thus, within the CD8 T cell lineage, Hobit is expressed in a Trm-specific manner.
To examine the function of Hobit and Blimp1 in Trm cell differentiation, we used a mouse model to generate skin Trm cells, by the intradermal injection of activated CD8 T cells, as previously described (1) . After transfer, wild-type (WT) CD8 T cells persisted in skin and acquired a Trm phenotype (Fig. 1, C and D, and fig. S2A ). Cotransferred Hobit-deficient CD8 T cells were reduced in skin, despite similar maintenance in spleen, as compared with WT cells (Fig. 1C) , which suggested that Hobit was specifically required for Trm cell development. Blimp1 was not essential for skin Trm cell formation by itself, but collaborated with Hobit in a synergistic manner (Fig. 1C and fig. S2, A and B) . Residual Hobit and Blimp1 doubly deficient [double-knockout (DKO)] CD8 T cells in the skin displayed reduced surface expression of Trm cell-associated molecules compared with WT CD8 T cells (Fig. 1D and fig. S2C ). To study Trm cell development during viral infection, we infected mice with HSV and analyzed endogenous CD8 T cell responses. We used mixedbone marrow (BM) chimeric mice, containing WT and mutant compartments at a 1:1 ratio, to minimize indirect effects through differences in viral clearance. This ratio was largely maintained in the antigen-specific CD8 T cells, regardless of location at the peak of the T cell response (Fig.  1E ). In line with previous findings (3, 4), Blimp1, but not Hobit, was required for the formation of short-lived effectors and granzyme B expression, which resulted in increased proportions of Blimp1-deficient memory precursors ( fig. S3,  A and B, and fig. S4 , A to G) and memory CD8 T cells (Fig. 1, E and F) . The combined loss of Hobit and Blimp1 strongly compromised development of skin Trm cells but not of circulating memory cells (Fig. 1, E and F) . After infection with LCMV, double deficiency in Hobit and Blimp1 abrogated the development of gut-resident CD8 T cells but not of splenic CD8 T cells ( fig. S5, A and B) . Thus, Hobit and Blimp1 cooperate to specifically promote Trm development.
Tissue residency has also been described for innate lymphocytes, including subpopulations of NK and NKT cells (5) (6) (7) (8) . Tissue-resident NK
